Numerous studies have evaluated bladder function measurements in women with lower urinary tract symptoms, yet few have evaluated these same outcomes in healthy women. We conducted a systematic review and meta-analysis of non-invasive bladder function tests (diaries, ultrasonography, and uroflowmetry) to identify reference values in order to describe "normality" in asymptomatic women.
INTRODUCTION AND OBJECTIVES:
Numerous studies have evaluated bladder function measurements in women with lower urinary tract symptoms, yet few have evaluated these same outcomes in healthy women. We conducted a systematic review and meta-analysis of non-invasive bladder function tests (diaries, ultrasonography, and uroflowmetry) to identify reference values in order to describe "normality" in asymptomatic women.
METHODS: A systematic search was conducted in 7 electronic databases from inception to February 2017, with handearching of reference lists. Observational studies with community-residing healthy women without lower urinary tract symptoms, urological disorders, progressive neurological diseases, renal disease, cancer, and catheter use were included. Pregnant and postpartum women were excluded. Two reviewers independently assessed studies for inclusion, extracted data, and evaluated quality. Discrepancies were resolved by a third reviewer. Outcomes included: urination frequencies, voided and postvoid residual volumes, and uroflowmetry values. Meta-analysis was performed using random-effects models to derive study-level pooled mean estimates and 95% confidence intervals, with heterogeneity assessed by I 2 statistic. RESULTS: Thirty-six studies met inclusion criteria, with 22 studies (2488 women) included in the meta-analyses. Studies were conducted in 11 countries, with individual sample sizes varying from 14 to 352. 
MP11-15 CHRONIC HIGH FAT DIET IMPAIRS DETRUSOR MITOCHONDRIAL FATTY ACID OXIDATION IN MALE BUT NOT FEMALE MICE
INTRODUCTION AND OBJECTIVES: Obesity increases the prevalence of bladder dysfunction in both males and females. The bladder's mucosal and detrusor smooth muscle layers are involved in bladder signaling and contraction, respectively. The underlying causes of obesity-induced bladder dysfunction in males and females are poorly understood. Mitochondrial dysfunction is common in the heart, liver and skeletal muscle with high fat diet. This study aims to determine the impact of long-term high fat diet (HFD) on bladder mucosal and detrusor mitochondrial respiration in male and female mice.
METHODS: Adult male and female mice were fed a control (10% kcal fat) or HFD (45% kcal fat; n[7/group) for 24 weeks. Bladders were collected, weighed and separated into mucosal and detrusor layers. Tissues were cut into strips, permeabilized, and placed in an OROBOROS Oxygraphy-2K to measure respiration. Substrates (pyruvate/malate, glutamate, L-octanoylcarnitine/malate, or succinate/ rotenone) were added with increasing concentrations of phosphocreatine for substrate-specific force-flow bioenergetic analysis. Respiratory conductance, the rate of change in respiration, was measured with increasing phosphocreatine concentration. Respiratory conductance is analogous to the cell's responsiveness to create ATP with respect to the substrate.
RESULTS: Chronic HFD increased body weight and decreased the bladder to body weight ratio in both sexes compared to control mice. Male HFD mucosal and detrusor force-flow respiration and respiratory conductance was decreased in the presence of fatty acid substrate L-octanoylcarnitine/malate. HFD male force-flow respiration and respiratory conductance was unchanged in the presence of pyruvate/ malate, glutamate, and succinate/rotenone. In HFD females, force-flow respiration and respiratory conductance were unchanged in presence of pyruvate/malate, glutamate, and L-octanoylcarnitine/malate. However, HFD female mucosal layer had decreased force-flow respiration with succinate/rotenone but no change in respiratory conductance.
CONCLUSIONS: Male mice chronically fed a HFD have decreased fatty acid metabolism within the mucosal and detrusor muscle layers whereas female mice are protected. Ongoing studies will determine if the excess lipids are accumulating within the bladder and if we can rescue fatty acid metabolism with co-factors such as L-carnitine or acetylCoA. Understanding bladder metabolic and bioenergetic sex differences will help to create more effective treatments for bladder dysfunction. C) activates the innate immune system and improves bladder cancer (BC) chemosensitivity. In this study, we evaluated the impact of convective hyperthermia on intravesical mitomycin C (MMC) pharmacokinetics in live porcine bladder models.
METHODS: Forty 60 kg female swine were anesthetized and catheterized with a 3-way, 16-F catheter. The Combat BRS device was used to heat the porcine bladders to a target temperature of 43 C with recirculating intravesical MMC (2 mg/mL) at doses of 40mg, 80mg and 120mg. Dwell-heat time ranged from 30 to 120 minutes, after which rapid necropsy with immediate flash freezing of tissues (bladder, lymph nodes, liver, kidney, spleen, heart and lung) occurred. Blood and urine were collected longitudinally. Serum and tissue MMC concentrations were measured by liquid chromatography tandem-mass spectrometry (Agilent 1200, Applied Biosciences/SCIEX API 5500 QTrap). Data acquisition and quantification was performed by Analyst 1.6.2 software.
RESULTS: As shown in the Table, 3 factors increased MMC absorption into the bladder: dwell time, drug concentration, and the presence of heat. Bladder MMC concentrations were, in general, significantly higher in pigs that underwent convective hyperthermia than in those that did not (it is uncertain why this relationship was not present at the 120 mg dose with 1-hour dwell time). The relationship between bladder penetration of drug and heating showed a weak linear relationship with dose (Kendall's tau [ 0.35). In the hyperthermia arm, drug penetration saturated at 80 mg dose, suggesting that with heating, drug absorption may saturate and not require higher doses to achieve the maximal biological effect. Importantly, convective hyperthermia did not increase the MMC concentration in the liver, heart, kidney, spleen, lung, lymph node tissue and plasma and is therefore not expected to result in excess toxicity in humans, even at the 120 mg dose.
CONCLUSIONS: Convective bladder hyperthermia using the Combat BRS device increases MMC penetration into the bladder wall but does not result in an increase of MMC levels in the liver, heart, kidney, spleen, lung, lymph node tissue and plasma. The use of hyperthermia may saturated drug delivery and allow lower doses. These data support the use of the Combat BRS device to improve MMC penetration into the bladder wall. is a serious problem causing severe or permanent disability. Even though various treatment methods with various cell types are respectively applied to the SCI patients, there is no efficient method yet. One of the challenging therapies for this problem is phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitors. The PTEN inhibitors have been used to facilitate neuroprotection and axonal outgrowth. Therefore, we investigated the effects of PTEN inhibitors on voiding and motor function after SCI.
Source of
METHODS: Female rats were randomly divided into five groups (n [ 10 in each group): the sham-operation group, the SCI-induced group, the SCI-induced and PTEN inhibitor type I treated group, the SCI-induced and PTEN inhibitor type II treated group, and the SCIinduced and PTEN inhibitor type III treated group. SCI was induced by contusion injury at T9-T10 level. After injury, PTEN inhibitor was directly administered to the site of injury for 14 days. Cystometry, Basso, Beattie and Bresnahan (BBB) scale test, ladder walking test, hematoxylin and eosin staining, and western blot for Brain-derived neurotrophic factor(BDNF), vascular endothelial growth factor(VEGF), nerve growth factor(NGF) were performed.
RESULTS: After PTEN inhibitor treatment, enhanced walking ability and coordinative function was observed. Cystometry showed improvement of increased contraction pressure and shortened contraction interval. Basal contraction pressure and time were increased in the PTEN inhibitor-treated groups compared with the SCI group, especially and basal contraction pressure was higher in the PTEN inhibitor type II and type III groups. This means that the SCI has damaged the urinary signaling system. However, PTEN inhibitor treatment can be considered to increase the signal of urination that caused the dysfunction due to the SCI. PTEN inhibitors significantly inhibited the overexpression of VEGF, BDNF, and NGF.
CONCLUSIONS: PTEN inhibitors inhibited overexpressed growth factors and promoted repair of damaged tissue. They also showed improved voiding and motor function. Therefore, we suggest that PTEN inhibitors as a new therapeutic agent that can be applied after SCI.
Source of Funding: None

MP11-18 ANALYSIS OF BLADDER CLOCK GENES IN LOWER URINARY TRACT DYSFUNCTION OF SPONTANEOUSLY HYPERTENSIVE RAT
Yusuke Kimura*, Masashi Honda, Ryo Sasaki, Panagiota Tsounapi, Shuichi Morizane, Katsuya Hikita, Mitsuhiko Osaki, Futoshi Okada, Atsushi Takenaka, Yonago, Japan INTRODUCTION AND OBJECTIVES: Circadian rhythms are regulated by clock gene products, and in the case of mammals, these clock gene products are present in most cells and organs. It is reported that transient receptor potential cation channel subfamily V member 4 (TRPV4), vesicular nucleotide transporter (VNUT), and Piezo1 show circadian rhythms in the bladder mucosa and that these circadian rhythms are hindered by clock gene abnormality. However, the effect of bladder clock genes on bladder dysfunction remains unclear. In this study, we investigate the expression and circadian rhythm of TRPV1, TRPV4, VUNT, Piezo1, and clock genes in the bladders of spontaneously hypertensive rats (SHR).
METHODS: Male Wistar rats (control group) and male SHRs (SHR group) were used in this study. The experimental animals were placed 12 h of alternating light and dark conditions. Upon completing
